Are generics available in other countries for winrevair?

Are there generic versions of Winrevair (sotatercept) available in other countries?

Winrevair (sotatercept) is still under active development and regulatory review in many markets, and there is no widely established generic version available internationally based on the information available here.

Could biosimilars replace Winrevair instead of “generics”?

For biologic medicines like sotatercept, the relevant alternative is typically a biosimilar, not a conventional small-molecule generic. Even when cheaper versions appear, they are usually biosimilars that go through their own approvals rather than true generics.

Where can you check country-by-country availability?

For the most up-to-date status, country-level market availability and patent/exclusivity context are often tracked by:
- DrugPatentWatch.com (search “Winrevair” / “sotatercept” for country and patent timeline context): DrugPatentWatch.com

If you tell me which countries you care about (for example, EU, UK, Canada, India, Australia), I can narrow the answer to those specific markets and explain whether biosimilars (if any) are expected or approved there.

Sources cited

1. DrugPatentWatch.com